GH-axis + recovery stack

Ipamorelin + Larazotide Acetate stack

A research-context overview of stacking Ipamorelin with Larazotide Acetate: the rationale, complementary benefits, side-effect overlap, and pharmacokinetic considerations. Educational only — never a recommendation.

Why this stack?

Pairing a Performance peptide like Ipamorelin with a Recovery peptide like Larazotide Acetate is one of the most common stack archetypes in the research literature. The Performance compound drives the GH/IGF-1 axis or anabolic signaling; the Recovery compound shortens the soft-tissue and inflammation tax of training, letting the anabolic signal land on healthier tissue. The two work on independent pathways, so timing concerns are minimal — most researchers dose them on separate clocks.

Performance

Ipamorelin

Gentle GH releaser that amps muscle growth and fat loss without the harsh sides.

Key benefits

  • Increases lean muscle mass
  • Accelerates fat loss
  • Improves sleep quality
  • Enhances recovery

Side effects to watch

  • Flushing
  • Headache
  • Lightheadedness
Reference dose
200-300 mcg · Daily (Night)
Recovery

Larazotide Acetate

Tight-junction regulator developed for celiac disease; reduces intestinal permeability.

Key benefits

  • Tightens intestinal junctions
  • Reduces leaky-gut markers
  • Studied in celiac disease

Side effects to watch

  • Headache
  • Nausea
  • Upper respiratory symptoms
Reference dose
0.5 mg · 3x daily, oral

Half-life considerations

Reference half-life data for one or both of these compounds is not in our table — see the individual peptide profiles for cited PK ranges.

Profile
Ipamorelin
Profile
Larazotide Acetate
Compare
Ipamorelin vs Larazotide Acetate

Educational use only

This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.